TAKEDA PHARMACEUTICAL CO LTD

Holdings History for Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Symbol: OVID on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 8,781,996 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

Takeda Pharmaceutical Company Limited ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID)

09 Dec 2025 - Takeda Pharmaceutical Company Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,781,996 shares of Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID). This represents 12% ownership of the company. This is the first filing by TAKEDA PHARMACEUTICAL CO LTD disclosing ownership of Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Takeda Pharmaceutical Company Limited	12%		$11,680,055	8,781,996			$1.33	13G/A	08 Dec 2025	09 Dec 2025, 21:02

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
30 Sep 2025	60%	0%	$9,791,595	7,531,996	$1.30	Q3 2025
30 Jun 2025	13%	0%	$2,485,380	7,531,996	$0.33	Q2 2025
31 Mar 2025	15%	0%	$2,349,805	7,531,996	$0.31	Q1 2025
31 Dec 2024	26%	0%	$7,011,884	7,531,996	$0.93	Q4 2024
30 Sep 2024	23%	0%	$8,887,755	7,531,996	$1.18	Q3 2024
30 Jun 2024	2.5%	0%	$5,792,461	7,531,996	$0.77	Q2 2024
31 Mar 2024	7.9%	0%	$22,972,588	7,531,996	$3.05	Q1 2024
31 Dec 2023	7.4%	0%	$24,253,027	7,531,996	$3.22	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.